Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

(BIOA) (BIOA) Stock Forecast & Price Target

(BIOA) logo
Get the Latest News and Ratings for BIOA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for (BIOA) and its competitors.

Sign Up

BIOA Analyst Ratings Over Time

TypeCurrent Forecast
11/22/23 to 11/21/24
1 Month Ago
10/23/23 to 10/22/24
3 Months Ago
8/24/23 to 8/23/24
1 Year Ago
11/22/22 to 11/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
N/A N/A
Buy
3 Buy rating(s)
3 Buy rating(s)
N/A N/A
Hold
0 Hold rating(s)
0 Hold rating(s)
N/A N/A
Sell
0 Sell rating(s)
0 Sell rating(s)
N/A N/A
Consensus Price Target$42.33$42.33N/AN/A
Forecasted Upside130.07% Upside78.25% UpsideN/AN/A
Consensus Rating
Buy
Buy
N/AN/A

BIOA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BIOA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

(BIOA) Stock vs. The Competition

Type(BIOA)Medical CompaniesS&P 500
Consensus Rating Score
3.00
2.80
2.50
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside130.07% Upside26,931.55% Upside9.81% Upside
News Sentiment Rating
Neutral News

See Recent BIOA News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/21/2024Citigroup
3 of 5 stars
S. Semenkow
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$45.00+88.60%
10/21/2024Jefferies Financial Group
2 of 5 stars
 Initiated CoverageBuy$42.00+76.03%
10/21/2024Morgan Stanley
3 of 5 stars
 Initiated CoverageOverweight$40.00+67.64%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 10:31 AM ET.


BIOA Forecast - Frequently Asked Questions

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for (BIOA) is $42.33, with a high forecast of $45.00 and a low forecast of $40.00.

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for (BIOA) in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BIOA shares.

According to analysts, (BIOA)'s stock has a predicted upside of 130.07% based on their 12-month stock forecasts.

(BIOA) has been rated by research analysts at Citigroup, Jefferies Financial Group, and Morgan Stanley in the past 90 days.

Analysts like (BIOA) more than other "medical" companies. The consensus rating for (BIOA) is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BIOA compares to other companies.


This page (NYSE:BIOA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners